Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2015-11-23

Original market date: See footnote 1

1997-02-07

Product name:

TRIANAL TABLET

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

01971409

Product Monograph/Veterinary Labelling:

Date: 2017-06-30 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

LABORATOIRE RIVA INC.
660 Boul. Industriel
Blainville
Quebec
Canada  J7C 3V4

Class: 

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

Schedule G (CDSA IV)  

American Hospital Formulary Service (AHFS): See footnote 3

28:08.04.24   SALICYLATES

Anatomical Therapeutic Chemical (ATC): See footnote 4

N02BA71  ACETYLSALICYLIC ACID, COMB WITH PSYCHOLEPTICS

Active ingredient group (AIG) number:See footnote 5

0301241001

List of active ingredient(s)
Active ingredient(s) Strength
ACETYLSALICYLIC ACID 330 MG
BUTALBITAL 50 MG
CAFFEINE 40 MG

Application information

Related information

Contact us

Version 3.9.1
Date modified: